<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="318">
  <stage>Registered</stage>
  <submitdate>29/08/2005</submitdate>
  <approvaldate>31/08/2005</approvaldate>
  <actrnumber>ACTRN12605000248662</actrnumber>
  <trial_identification>
    <studytitle>Meal Replacement Study</studytitle>
    <scientifictitle>Study of Meal Replacement with Formula Diet in achieving weight loss and improved metabolic control in people with type 2 diabetes</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will be randomised to either group A (diet) or B (meal replacement) for a period of six months.  Group A will receive conventional low calorie diet and physical activity guidance once per month during the six months and Group B will receive the same advice and in addition replace one meal each day with a meal replacement, Microdiet (MD).</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in body weight between baseline and 6 months.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in metabolic control of diabetes</outcome>
      <timepoint>At three and six months as measured by HbA1C%, blood pressure and lipids (TG, TC, HDL-C &amp; LDL-C).</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Type 2 diabetes. Body mass index &gt; 29kg/m2.</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Severe underlying disease prohibiting low calorie diet therapyAllergy to MDPregnant or breastfeedingNeed for protein restrictionGP considers the participant inappropriate.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes are held by an independent person, and opened by the independent person to assign the intervention group</concealment>
    <sequence>Computer-generated random numbers (using Microsoft Excel), in blocks of 2-8 are used.  These are stratified by diabetes treatment modality into 2 strata - insulin or non-insulin controlled.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>3/06/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Sunny Health Co., Japan</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Japan</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Sunny Health Co.</fundingname>
      <fundingaddress />
      <fundingcountry>Japan</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>International Diabetes Institute</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor Jonathan Shaw</name>
      <address>Deputy Director 
International Diabetes Institute
250 Kooyong Road
Caulfield VIC 3162</address>
      <phone>+61 3 92585047</phone>
      <fax />
      <email>jshaw@idi.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Miss Cathie Adams</name>
      <address>International Diabetes Institute
250 Kooyong Road
Caulfield VIC 3162</address>
      <phone>+61 3 92585000</phone>
      <fax />
      <email>cadams@idi.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>